Aarti Drugs Share Price Live

History

Business Segments

1. Active Pharmaceutical Ingredients (APIs) - The company is a leading API producer of over 50 molecules for antibiotics, antiprotozoal, anti-inflammatory, antidiabetic and antifungal purposes. This segment contributed around 85% of the total revenue in FY 2023, based on 9 manufacturing units and 30 APIs developed in the 5 years preceding FY 2023.
2. Formulations - For this segment, the company adopted a flexible manufacturing approach with the combination of in-house manufacturing as well as an outsourcing model supported by in-house R&D.
3. Speciality Chemicals, Intermediates and others - This segment involves being a backward integrated approach, supplying intermediates of antibiotics, antifungal, anti-inflammatory and cardiovascular to the API manufacturers. In this segment, they have a special focus on Benzene and Chloro-sulphonic chemistry

1. Pinnacle Life Science Private Limited - Pinnacle Life Science Private Limited (PLSPL) is a wholly-owned subsidiary founded to become a global leader in high-quality and cost-effective pharmaceutical formulations.
2. Aarti Speciality Chemicals Limited - This is a wholly-owned subsidiary dedicated to speciality chemicals.
3. Pinnacle Chile SpA (a foreign subsidiary) -This company supports the marketing of medication formulations and participates in tenders in Santiago, Chile.

Key Personnel

Corporate Actions

1. It issued bonus shares at a 3:1 ratio with the record date of October 1, 2020.
2. It issued bonus shares at a 1:1 ratio with the record date of March 25, 2015.

1. The company performed a buyback of its shares with a record date of August 4, 2023. 
2. The company performed a buyback of its shares with the record date of April 1, 2021.
3. The company performed a buyback of its shares with the record date of March 29, 2019.
4. The company performed a buyback of its shares with the record date of January 19, 2018.
5. The company performed a buyback of its shares with a record date of November 2, 2016.

• In 2015, the company acquired 100% equity of Pinnacle Life Science Pvt Ltd. However, this subsidiary was wound up in 2021.
• An amalgamation of a wholly owned subsidiary, Suyash Laboratories Ltd, into the company became operative effective from April 1, 2011.
• In 1996, multiple companies were amalgamated into Aarti Drugs. These included Rupal Chemical Industries Ltd, Rashesh Chemicals & Pharmaceuticals Ltd, Manjarati Chemicals Pvt Ltd, Manjarati Plastisizer Pvt Ltd, Effective Chemicals Pvt Ltd, Star Aluminium Industries Ltd and Avez Wire Industries Ltd.